Skip to main content
IDAI
NASDAQ Technology

T Stamp Schedules Shareholder Vote to Ratify $5.25M Warrant Exercise, Critical for 'Going Concern' Status

Analysis by Arik Shkolnikov
Sentiment info
Neutral
Importance info
8
Price
$2.07
Mkt Cap
$11.592M
52W Low
$1.8
52W High
$5.28
Market data snapshot near publication time

summarizeSummary

T Stamp Inc. has scheduled a shareholder meeting to vote on the ratification of Private Placement Warrants, which, if approved and exercised, could provide the company with approximately $5.25 million in much-needed capital amidst its 'going concern' warning.


check_boxKey Events

  • Shareholder Meeting Scheduled

    T Stamp Inc. will hold its deferred 2025 Annual Meeting of Stockholders on Tuesday, July 7, 2026, to vote on several proposals, including the ratification of warrants.

  • Vote on Warrant Ratification

    Shareholders will vote on Proposal 3 to ratify the issuance of Private Placement Warrants (Series A and Series B) and up to 648,148 shares of Class A Common Stock upon their exercise, as required by Nasdaq Listing Rule 5635(d). These warrants were part of a December 2024 Securities Purchase Agreement with Armistice Capital Master Fund Ltd.

  • Potential Capital Infusion

    If approved and all Private Placement Warrants are exercised for cash, the company could receive approximately $5.25 million in gross proceeds. This capital is designated for working capital, capital expenditures, and general corporate purposes.

  • Significant Dilution Potential

    The exercise of the 648,148 Private Placement Warrants would result in approximately 11.57% dilution to existing shareholders, based on 5,599,964 shares outstanding as of May 13, 2026.


auto_awesomeAnalysis

T Stamp Inc. is seeking shareholder approval for the issuance of Private Placement Warrants and the shares issuable upon their exercise, which could bring in approximately $5.25 million in gross proceeds. This vote is critical for the company, which has a 'going concern' warning, as it has previously failed to obtain a quorum for this approval multiple times. While the exercise of these warrants would be dilutive to existing shareholders, the capital infusion is essential for the company's working capital and general corporate purposes, potentially extending its financial runway.

At the time of this filing, IDAI was trading at $2.07 on NASDAQ in the Technology sector, with a market capitalization of approximately $11.6M. The 52-week trading range was $1.80 to $5.28. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed IDAI - Latest Insights

IDAI
May 20, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
8
IDAI
May 14, 2026, 4:42 PM EDT
Source: Reuters
Importance Score:
8
IDAI
May 14, 2026, 4:28 PM EDT
Filing Type: 8-K
Importance Score:
8
IDAI
May 14, 2026, 4:28 PM EDT
Filing Type: 10-Q
Importance Score:
9
IDAI
Apr 24, 2026, 5:01 PM EDT
Filing Type: S-3
Importance Score:
9
IDAI
Mar 31, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
9
IDAI
Mar 31, 2026, 4:07 PM EDT
Filing Type: 10-K
Importance Score:
9
IDAI
Mar 12, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
IDAI
Mar 05, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
IDAI
Feb 02, 2026, 1:37 PM EST
Filing Type: 8-K
Importance Score:
9